HR919Passed House

Chronic Disease Flexible Coverage Act

Share:
Introduced
In Committee
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-02-04
Introduced
2
Cosponsors
HR
ⓘ
Type

Sponsor

Vern Buchanan
Vern Buchanan
Republican · FL · Representative
Votes with party: 97.3% (552 recorded votes)

Full profile: /officials/B001260

Source: Congress.gov · FEC

Cosponsors (2)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

2 cosponsors on record at Congress.gov. The named list is syncing into Govwatch and will appear here shortly — view on Congress.gov in the meantime.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Received in the Senate and Read twice and referred to the Committee on Finance.

2025-03-05

Source: Congress.gov

Committee Activity

Currently in

Plain-English Summary

Chronic Disease Flexible Coverage Act This bill provides statutory authority for guidance from the Internal Revenue Service (IRS) that expands the types of preventive care that may be offered under a high deductible health plan (HDHP) without requiring a deductible or with a deductible below the minimum threshold. Under current law, to be considered health savings account-eligible, an HDHP must have a deductible above a certain minimum threshold amount, which is adjusted annually. However, an HDHP may cover certain types of preventive care without requiring a deductible or with a deductible below the minimum threshold. The IRS issued guidance expanding the types of preventive care that may be covered by an HDHP without requiring a deductible or with a deductible below the minimum threshold to include angiotensin converting enzyme inhibitors for individuals with congestive heart failure, diabetes, or coronary artery disease; anti-resorptive therapy for individuals with osteoporosis or osteopenia; beta-blockers for individuals with congestive heart failure or coronary artery disease; blood pressure monitors for individuals with hypertension; inhaled corticosteroids and peak flow meters for individuals with asthma; insulin and other glucose lowering agents, retinopathy screening, glucometers, and hemoglobin A1c testing for individuals with diabetes; international normalized ratio testing for individuals with liver disease or bleeding disorders; low-density lipoprotein testing for individuals with heart disease; statins for individuals with heart disease or diabetes; and selective serotonin reuptake inhibitors for individuals with depression. The bill provides statutory authority for the IRS's guidance.

Plain-English rewrite of the Congressional Research Service summary published on Congress.gov. Cached and reviewed.

Subjects

Taxation
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.